tiprankstipranks
Trending News
More News >
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
US Market

Sarepta Therapeutics (SRPT) Ratios

Compare
3,549 Followers

Sarepta Therapeutics Ratios

SRPT's free cash flow for Q4 2024 was $0.80. For the 2024 fiscal year, SRPT's free cash flow was decreased by $ and operating cash flow was $0.27. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.20 3.95 4.13 5.75 5.97
Quick Ratio
3.18 3.45 3.80 5.34 5.42
Cash Ratio
1.51 0.66 1.56 4.67 3.61
Solvency Ratio
0.12 -0.20 -0.24 -0.17 -0.23
Operating Cash Flow Ratio
-0.28 -0.77 -0.53 -0.98 0.26
Short-Term Operating Cash Flow Coverage
0.00 -4.75 0.00 0.00 0.00
Net Current Asset Value
$ 638.03M$ 174.09M$ -185.56M$ 384.13M$ 262.24M
Leverage Ratios
Debt-to-Assets Ratio
0.34 0.43 0.52 0.36 0.36
Debt-to-Equity Ratio
0.88 1.63 4.20 1.23 1.41
Debt-to-Capital Ratio
0.47 0.62 0.81 0.55 0.58
Long-Term Debt-to-Capital Ratio
0.43 0.57 0.80 0.54 0.57
Financial Leverage Ratio
2.59 3.80 8.13 3.39 3.92
Debt Service Coverage Ratio
16.72 -3.57 -11.19 -4.82 -7.58
Interest Coverage Ratio
11.86 -12.17 -10.07 -7.08 -9.41
Debt to Market Cap
0.10 0.14 0.14 0.15 0.07
Interest Debt Per Share
14.32 15.36 19.08 14.79 14.53
Net Debt to EBITDA
0.72 -2.20 -1.12 3.19 0.95
Profitability Margins
Gross Profit Margin
83.22%87.91%85.00%86.17%88.26%
EBIT Margin
14.68%-40.06%-68.24%-50.64%-91.30%
EBITDA Margin
17.51%-35.32%-62.39%-43.61%-83.94%
Operating Profit Margin
11.47%-21.54%-57.47%-64.07%-104.46%
Pretax Profit Margin
13.71%-41.83%-73.95%-59.69%-102.40%
Net Profit Margin
12.37%-43.11%-75.40%-59.66%-102.60%
Continuous Operations Profit Margin
12.37%-43.11%-75.40%-59.66%-102.60%
Net Income Per EBT
90.21%103.05%101.96%99.96%100.19%
EBT Per EBIT
119.58%194.19%128.68%93.16%98.03%
Return on Assets (ROA)
5.94%-16.42%-22.49%-13.30%-18.57%
Return on Equity (ROE)
15.40%-62.37%-182.75%-45.13%-72.74%
Return on Capital Employed (ROCE)
6.75%-10.26%-21.37%-16.69%-21.96%
Return on Invested Capital (ROIC)
6.09%-10.09%-21.66%-16.68%-22.01%
Return on Tangible Assets
5.98%-16.57%-22.54%-13.36%-18.65%
Earnings Yield
2.03%-6.02%-6.20%-5.72%-4.17%
Efficiency Ratios
Receivables Turnover
2.93 2.83 3.59 4.09 3.99
Payables Turnover
1.49 0.91 1.46 1.26 0.57
Inventory Turnover
0.43 0.47 0.69 0.52 0.27
Fixed Asset Turnover
3.89 3.48 3.81 2.97 1.91
Asset Turnover
0.48 0.38 0.30 0.22 0.18
Working Capital Turnover Ratio
0.89 0.64 0.46 0.33 0.33
Cash Conversion Cycle
737.24 512.53 383.43 500.97 787.65
Days of Sales Outstanding
124.69 129.08 101.59 89.26 91.59
Days of Inventory Outstanding
857.84 783.83 531.82 700.34 1.34K
Days of Payables Outstanding
245.29 400.38 249.98 288.62 639.74
Operating Cycle
982.52 912.91 633.41 789.60 1.43K
Cash Flow Ratios
Operating Cash Flow Per Share
-2.16 -5.42 -3.72 -5.45 1.38
Free Cash Flow Per Share
-3.60 -6.37 -4.07 -5.93 0.32
CapEx Per Share
1.44 0.82 0.35 0.47 1.05
Free Cash Flow to Operating Cash Flow
1.67 1.17 1.09 1.09 0.24
Dividend Paid and CapEx Coverage Ratio
-1.50 -6.58 -10.55 -11.51 1.31
Capital Expenditure Coverage Ratio
-1.50 -6.58 -10.55 -11.51 1.31
Operating Cash Flow Coverage Ratio
-0.15 -0.36 -0.20 -0.39 0.10
Operating Cash Flow to Sales Ratio
-0.11 -0.40 -0.35 -0.63 0.20
Free Cash Flow Yield
-2.96%-6.60%-3.14%-6.58%0.19%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
49.14 -16.62 -16.13 -17.47 -23.98
Price-to-Sales (P/S) Ratio
6.08 7.17 12.16 10.43 24.61
Price-to-Book (P/B) Ratio
7.57 10.37 29.47 7.89 17.45
Price-to-Free Cash Flow (P/FCF) Ratio
-33.73 -15.14 -31.86 -15.19 526.07
Price-to-Operating Cash Flow Ratio
-56.18 -17.78 -34.87 -16.51 123.67
Price-to-Earnings Growth (PEG) Ratio
-0.34 0.60 -0.29 0.63 0.90
Price-to-Fair Value
7.57 10.37 29.47 7.89 17.45
Enterprise Value Multiple
35.43 -22.49 -20.61 -20.71 -28.37
Enterprise Value
11.80B 9.88B 12.00B 6.34B 12.86B
EV to EBITDA
35.43 -22.49 -20.61 -20.71 -28.37
EV to Sales
6.20 7.95 12.86 9.03 23.81
EV to Free Cash Flow
-34.43 -16.79 -33.68 -13.16 509.06
EV to Operating Cash Flow
-57.34 -19.72 -36.87 -14.31 119.67
Tangible Book Value Per Share
15.79 8.98 4.31 11.24 9.60
Shareholders’ Equity Per Share
16.07 9.30 4.40 11.42 9.77
Tax and Other Ratios
Effective Tax Rate
0.10 -0.03 -0.02 <0.01 >-0.01
Revenue Per Share
20.01 13.46 10.66 8.64 6.93
Net Income Per Share
2.47 -5.80 -8.03 -5.15 -7.11
Tax Burden
0.90 1.03 1.02 1.00 1.00
Interest Burden
0.93 1.04 1.08 1.18 1.12
Research & Development to Revenue
0.42 0.71 0.94 1.10 1.34
SG&A to Revenue
0.29 0.36 0.48 0.40 0.59
Stock-Based Compensation to Revenue
0.10 0.15 0.25 0.16 0.20
Income Quality
-0.87 0.93 0.46 1.06 -0.19
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis